Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · IEX Real-Time Price · USD
49.57
+0.31 (0.63%)
At close: Jul 19, 2024, 4:00 PM
49.55
-0.02 (-0.04%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
Rhythm Pharmaceuticals Market Cap
Rhythm Pharmaceuticals has a market cap or net worth of $3.02 billion as of July 22, 2024. Its market cap has increased by 235.19% in one year.
Market Cap
3.02B
Enterprise Value
2.82B
1-Year Change
235.19%
Ranking
Category
Stock Price
$49.57
Market Cap Chart
Since October 5, 2017, Rhythm Pharmaceuticals's market cap has increased from $813.90M to $3.02B, an increase of 271.35%. That is a compound annual growth rate of 21.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 3.02B | 11.25% |
| Dec 29, 2023 | 2.72B | 65.56% |
| Dec 30, 2022 | 1.64B | 227.07% |
| Dec 31, 2021 | 501.70M | -61.82% |
| Dec 31, 2020 | 1.31B | 30.30% |
| Dec 31, 2019 | 1.01B | 9.04% |
| Dec 31, 2018 | 925.00M | 16.66% |
| Dec 29, 2017 | 792.90M | -2.58% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ADMA Biologics | 3.10B |
| iRhythm Technologies | 3.08B |
| Oscar Health | 3.08B |
| Amicus Therapeutics | 3.07B |
| Denali Therapeutics | 3.06B |
| ICU Medical | 2.98B |
| ACADIA Pharmaceuticals | 2.93B |
| Azenta | 2.88B |